Equities research analysts forecast that STRATA Skin Sciences Inc (NASDAQ:SSKN) will post $7.64 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for STRATA Skin Sciences’ earnings, with estimates ranging from $7.60 million to $7.67 million. STRATA Skin Sciences reported sales of $7.48 million during the same quarter last year, which indicates a positive year-over-year growth rate of 2.1%. The firm is expected to report its next quarterly earnings report on Thursday, November 8th.

According to Zacks, analysts expect that STRATA Skin Sciences will report full-year sales of $29.70 million for the current financial year, with estimates ranging from $29.40 million to $30.00 million. For the next financial year, analysts expect that the company will report sales of $34.15 million, with estimates ranging from $33.80 million to $34.50 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow STRATA Skin Sciences.

STRATA Skin Sciences (NASDAQ:SSKN) last released its quarterly earnings data on Monday, August 13th. The medical device company reported ($0.02) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.01. STRATA Skin Sciences had a negative return on equity of 27.01% and a negative net margin of 63.07%. The business had revenue of $7.53 million for the quarter, compared to analyst estimates of $6.84 million.

SSKN has been the topic of several recent research reports. HC Wainwright set a $3.00 price objective on STRATA Skin Sciences and gave the stock a “buy” rating in a research report on Thursday, May 31st. ValuEngine upgraded STRATA Skin Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, July 5th. Dawson James initiated coverage on STRATA Skin Sciences in a research report on Tuesday, September 4th. They issued a “buy” rating on the stock. Finally, Zacks Investment Research lowered STRATA Skin Sciences from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 1st.

Several large investors have recently made changes to their positions in SSKN. Macquarie Group Ltd. lifted its position in shares of STRATA Skin Sciences by 89.7% during the 2nd quarter. Macquarie Group Ltd. now owns 134,033 shares of the medical device company’s stock valued at $275,000 after buying an additional 63,393 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of STRATA Skin Sciences by 164.6% during the 2nd quarter. Renaissance Technologies LLC now owns 293,499 shares of the medical device company’s stock valued at $602,000 after buying an additional 182,579 shares in the last quarter. Menora Mivtachim Holdings LTD. purchased a new position in shares of STRATA Skin Sciences during the 2nd quarter valued at approximately $1,138,000. Finally, Nantahala Capital Management LLC purchased a new position in shares of STRATA Skin Sciences during the 2nd quarter valued at approximately $4,261,000. Hedge funds and other institutional investors own 27.47% of the company’s stock.

STRATA Skin Sciences stock opened at $3.50 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 4.20 and a current ratio of 4.77. STRATA Skin Sciences has a 12 month low of $1.06 and a 12 month high of $3.88. The company has a market capitalization of $109.89 million, a price-to-earnings ratio of 1.76 and a beta of 0.69.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

Further Reading: Why do companies issue stock splits?

Get a free copy of the Zacks research report on STRATA Skin Sciences (SSKN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.